Celebrex Medication Labeling information
This section provides information on past and present label descriptions for the Celebrex medication.
These Celebrex medication labels include the pharmacological breakdown, chemical structure, warnings, indications, precautions, pharmcokinetics, and contraindications for the use of the Celebrex medication.
Pfizer submitted two seperate New Drug Applications (NDA's) to the FDA for it's Celebrex medication, so some of these documents are only for one or the other.
Both Celebrex Medication NDAs:
Questions and Answers Celebrex labeling change - warfarin interaction
Celebrex Labeling Changes June 7, 2002
Celebrex Medication NDA: 020998
Weitz & Luxenberg is no longer accepting Celebrex cases.
see also:
Label: 6/7/2002
Celebrex for Arthritis Label Change: 6/7/2002June 7, 2002 label changes for Celebrex, a drug for arthritis
Label: 6/7/2004
Celebrex Labeling Description: 6/7/2004Official FDA labeling description of Celebrex from June 7, 2002
Official Documents
Celebrex Public CommentOfficial Comments on the Risks and Side Effects of Celebrex


